Antidiuresis therapy: mechanism of action and clinical implications.

Jens Peter Nørgaard, Hashim Hashim, Lars Malmberg, Dudley Robinson

Journal: Neurourology and urodynamics 2008;26(7):1008-13

PMID: 17480030

Abstract

Abnormalities of micturition occur in many different diseases, have a variety of causes and take several forms. This review will focus exclusively on those abnormalities in which antidiuretic therapy may be of benefit. These conditions are primarily characterized by an increase in the total amount of urine produced (polyuria) or a circadian shift in the control of urine production and/or voiding (nocturnal enuresis, nocturia).

Address: Ferring Pharmaceuticals A/S, Copenhagen, Denmark. [email protected]

DOI: 10.1002/nau.20437

Link outs

Subscription / membership required

Full Text Sources:

https://doi.org/10.1002/nau.20437

MeSH Terms: Antidiuretic Agents, Deamino Arginine Vasopressin, Humans, Nocturnal Enuresis, Polyuria, Quality of Life, Urination Disorders, Water